Control of Lipogenesis and Hepatic Steatosis by Caspase-2
Caspase-2 对脂肪生成和肝脂肪变性的控制
基本信息
- 批准号:10322660
- 负责人:
- 金额:$ 41.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationActive SitesAdaptor Signaling ProteinAdipose tissueAffectBenignBindingBinding ProteinsCASP2 geneCellsCholesterolChronicComplexConsumptionCuesDeath DomainDevelopmentDietDown-RegulationEndoplasmic ReticulumEnergy MetabolismFatty LiverFatty acid glycerol estersFeedbackFructoseGenesGeneticGenetic TranscriptionGolgi ApparatusHepaticHepatocyteHigh Fat DietHypoxiaIncidenceInflammationInsulinInsulin ResistanceKnock-in MouseKnockout MiceLightLipidsLiverMalignant NeoplasmsMediatingMembraneMetabolicMetabolic DiseasesModelingMusMutant Strains MiceN-terminalNutritionalObesityPathway interactionsPatientsPeptide HydrolasesPeripheralPharmacologyPhosphorylationPreparationPreventionPrimary carcinoma of the liver cellsProductionProtein Activation PathwayProtein IsoformsProtein PrecursorsProteinsProteolysisProto-Oncogene Proteins c-aktRefractoryRegulationResistanceResponse ElementsRoleSCAP proteinSignaling ProteinSiteStarvationSterolsSucroseTertiary Protein StructureTestingTissue ExpansionTissuesTriglyceridesType 2 diabeticUnsaturated Fatty AcidsUp-RegulationUrokinaseVesicleadenoviral-mediatedcholesterol biosynthesisendoplasmic reticulum stressexperimental studyfeedingimprovedin vivoinsulin signalinginterestlipid biosynthesislipid metabolismnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnutritionpreventprotein activationprotein complexprotein transportreconstitutionresponsesimple steatosissite-1 proteasestressoruptakewestern diet
项目摘要
PROJECT SUMMARY
Non-alcoholic fatty liver disease (NAFLD) is a common metabolic disorder whose US incidence exceeds
30%. While NAFLD manifests as benign steatosis, in about 15-20% of patients it assumes a much more
aggressive form – non-alcoholic steatohepatitis (NASH). The switch from benign simple steatosis to NASH is
poorly understood, but was suggested to depend on ER stress. Indeed, by feeding MUP-uPA mice, which are
prone to liver ER stress caused by hepatocyte-specific urokinase plasminogen activator (uPA) expression, a
high-fat diet (HFD) we established a faithful model of NASH that readily progresses to hepatocellular carcinoma
(HCC). HFD-fed MUP-uPA mice show ER-stress-dependent and persistent activation of sterol response element
binding proteins (SREBP) 1 and 2, which control de novo lipogenesis (DNL) and cholesterol biosynthesis.
Notably, SREBP1 and 2 remain activated in the MUP-uPA liver without any sign of feedback inhibition, which
shuts down their activity in lipid-loaded cells. DNL is also chronically elevated in NAFLD and hepatic
accumulation of free cholesterol was suggested to convert simple steatosis to NASH. Investigating how liver ER
stress causes persistent SREBP activation, we uncovered a previously unknown pathway in which caspase-2
(Casp2), whose expression is ER-stress-inducible, leads to constitutive activation of site 1 protease (S1P),
thereby initiating SCAP-independent SREBP cleavage in the ER. Casp2-mediated cleavage and activation of
S1P seems to occur in NASH patients and genetic ablation or pharmacological inhibition of Casp2 in MUP-uPA
mice blocks hepatic steatosis and NASH development. To fully establish the mechanistic aspects of this pathway
and its role in hepatic steatosis, we will investigate whether it functions in liver-specific SCAP knockout mice and
determine whether liver-specific Casp2 ablation affects peripheral adiposity and improves energy expenditure in
addition to preventing HFD-induced hepatic steatosis and its progression to NASH. We will also generate knockin
mice that express a Casp2-resistant (C2R) form of S1P and determine whether they are protected from ER-
stress induced hepatic steatosis and adipose tissue expansion. As ER-stress-mediated Casp2 activation and
S1P cleavage seem to depend on Tp53 activity, which results in induction of the Casp2 activator PIDD, we will
examine the role of Tp53 and PIDD in Casp2-dependent S1P cleavage, SREBP1/2 activation, and hepatic
steatosis, thereby establishing a key metabolic function for Tp53 outside of cancer. Finally, we will examine the
hypothesis that the original function of the Casp2-dependent S1P-SREBP activation pathway was to promote
energy storage in the form of liver fat during periods of hypernutrition in preparation for long-term starvation.
While clarifying the role of Casp2-mediated SREBP activation in hepatic steatosis and NASH, these studies will
shed new light on the poorly understood phenomenon of selective insulin resistance, in which hepatic DNL
remains elevated despite diminished insulin signaling.
项目总结
非酒精性脂肪性肝病(NAFLD)是一种常见的代谢性疾病,其发病率在美国超过
30%。虽然NAFLD表现为良性脂肪变性,但在大约15%-20%的患者中,它表现为更多
侵袭型--非酒精性脂肪性肝炎(NASH)。从良性单纯性脂肪变性到NASH的转变是
人们对此知之甚少,但建议依赖内质网应激。事实上,通过喂食MUP-uPA小鼠,它们是
肝细胞特异性尿激酶型纤溶酶原激活物(UPA)表达易导致肝脏内质网应激
高脂饮食(HFD)我们建立了一种可靠的NASH模型,该模型很容易进展为肝细胞癌
(肝细胞癌)。高脂饲料喂养的MUP-uPA小鼠表现出内质网应激依赖和固醇反应元件的持续激活
结合蛋白(SREBP)1和2,控制新生脂肪生成(DNL)和胆固醇的生物合成。
值得注意的是,SREBP1和2在MUP-uPA肝脏中保持激活,没有任何反馈抑制的迹象,这
关闭它们在脂类细胞中的活动。在NAFLD和肝脏中,DNL也慢性升高
游离胆固醇的积累被认为是将单纯性脂肪变性转化为NASH的原因。研究肝脏ER是如何
应激导致SREBP的持续激活,我们发现了一个以前未知的途径,其中caspase-2
(Casp2),其表达是内质网应激诱导的,导致1位点蛋白酶(S1P)的结构性激活,
从而在内质网中启动不依赖于SCAP的SREBP切割。Casp2介导的细胞分裂和激活
NASH患者中似乎存在S1P和MUP-uPA中Casp2的基因消融或药物抑制
小鼠阻止肝脏脂肪变性和NASH的发展。要完全建立这条途径的机械性方面
以及它在肝脏脂肪变性中的作用,我们将研究它在肝脏特异性SCAP基因敲除小鼠和
确定肝脏特异性Casp2消融是否影响外周脂肪和改善能量消耗
除了预防HFD诱导的肝脏脂肪变性及其进展为NASH外。我们还将生成敲门声
表达Casp2抗性(C2R)形式的S1P并确定它们是否受到ER-
应激导致肝脏脂肪变性和脂肪组织扩张。AS内质网应激介导的Casp2激活和
S1P的切割似乎依赖于TP53的活性,这导致了Casp2激活剂PIDD的诱导,我们将
检测TP53和PIDD在Casp2依赖的S1P裂解、SREBP1/2激活和肝脏中的作用
脂肪变性,从而建立了癌症外TP53的关键代谢功能。最后,我们将研究
假设依赖Casp2的S1P-SREBP激活通路的原始功能是促进
在营养过剩时期以肝脏脂肪的形式储存能量,为长期饥饿做准备。
在阐明Casp2介导的SREBP激活在肝脏脂肪变性和NASH中的作用的同时,这些研究将
揭示了选择性胰岛素抵抗这一鲜为人知的现象,在这种现象中,肝脏DNL
尽管胰岛素信号减弱,但仍保持高水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Karin其他文献
Michael Karin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Karin', 18)}}的其他基金
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
NF-kappaB 和线粒体信号作为炎症的正向和负向调节剂
- 批准号:
10516935 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
研究肝内胆管癌发病机制和免疫生物学并改进其免疫治疗的新小鼠模型
- 批准号:
10711615 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
胶原及其裂解产物对 PDAC 代谢和免疫的调节
- 批准号:
10708168 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
胶原及其裂解产物对 PDAC 代谢和免疫的调节
- 批准号:
10517874 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
NRF2-FBP1 交叉调节环路以及健康和患病肝脏代谢的控制
- 批准号:
10503841 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
NRF2-FBP1 交叉调节环路以及健康和患病肝脏代谢的控制
- 批准号:
10670920 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
The effect of cancer cell produced collagen 1 homotrimers on DDR1 signaling activation by microenvironmental collagen 1 fragments.
癌细胞产生的胶原蛋白 1 同源三聚体对微环境胶原蛋白 1 片段激活 DDR1 信号传导的影响。
- 批准号:
10831212 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
NF-kappaB 和线粒体信号作为炎症的正向和负向调节剂
- 批准号:
10182897 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
NF-kappaB 和线粒体信号作为炎症的正向和负向调节剂
- 批准号:
10266224 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
Caspase-2 对脂肪生成和肝脂肪变性的控制
- 批准号:
10083211 - 财政年份:2019
- 资助金额:
$ 41.77万 - 项目类别:
相似海外基金
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 41.77万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




